Sen. @hassan.senate.gov (D-NH): What are the real impacts of these patent games on patients?

Dr. @wbfeldman.bsky.social: These patent games can delay generic and biosimilar competition, which keep prices high...patients can’t afford their medications and we see worse clinical outcomes.

Senator Susan Collins (R-ME) took time during a recent hearing on 340B reform to highlight the importance of patent reform.

Watch the full exchange here👇

Last week, the Senate HELP Committee held a hearing on 340B reform. During the hearing, Sen. Hawley (R-MO) asked @wbfeldman.bsky.social how we can lower drug prices for Americans. Dr. Feldman outlined several steps we can take while making clear that patent reform is critical.

AbbVie used its patent thicket to block six competitors from launching cheaper versions of a $220,000 cancer drug.

SEN. BLUMENTHAL: Do all of you agree that reforms in the patent laws would enable lower costs for consumers?

…Yes

…Yes

…Yes

…Yes